Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomised, Double-blind Placebo Controlled Trial on the Efficacy and Safety of add-on Metformin to Conventional Immunosuppressants in Systemic Lupus Erythematosus
Conditions
Interventions
metformin
placebo
Locations
1
China
Ethics Committee of Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
Start Date
May 24, 2016
Primary Completion Date
December 13, 2017
Completion Date
December 7, 2018
Last Updated
September 17, 2019
NCT06647069
NCT07371468
NCT06333483
NCT07219563
NCT06875960
NCT07413341
Lead Sponsor
RenJi Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions